Six topics of discussion have been selected based on an extensive consultation process among ESOT’s Sections & Committees. These topics are the focus of the workstreams, managed by leaders in the field, who will connect with peers and mentors. It is our goal to build an expanded network, trigger new research, collaboration, exchange and discussion.

The discussion starts in the workstreams and continues on site at TLJ 2.0 during the Consensus Workshops (WS) on Day 1. The outcomes are shared and presented at the plenary session for open discussion on Day 2. 

WS01 – New Surrogate endpoints in transplantation

This consensus workshop will focus on endpoints solely on “how to define successful kidney transplantation”. This focuses on the innovative organ sources, like xenotransplants, 3D printed organs, lab grown organs, currently not used resuscitated organs using innovative perfusion techniques etc.

Workstream led and moderated by Maarten Naesens and Stefan Schneeberger

WS02 – CMV infection and disease

This workstream focuses on describing the state of the art of the prevention and treatment of CMV infection in solid organ transplant recipients.

Workstream led by Paolo Antonio Grossi and moderated by Maria Simonenko and Cristina Rovelli

This workstream is kindly supported by an unrestricted grant from MSD

WS03 – Cancer in pre and post transplant patients

The aim of this workstream is to establish a consensus on key questions concerning cancer in solid organ transplant candidates and recipients namely, what are the changes of immunosuppressive therapy that can currently be recommended in transplant recipients with skin and non-skin cancers undergoing chemotherapy/radiotherapy and/or immunotherapy, what are the new principles that should guide the choice of withholding transplantation in transplant candidates with a history of cancer.

Workstream led by Umberto Maggiore and moderated by Ilaria Gandolfini and  Alessandra Palmisano

WS04 – NRP after DCD

This workstream aims to provide an evidence based answer to the following question: Should NRP become standard of care in DCD donation?

Led by Ina Jochmans and moderated by
Maria Irene Bellini

WS05 – It’s not only extended donor criteria, it’s extending the donor pool

Donation and transplantation is a going-on discipline. Organ donors and recipients are time by time more complex from the medical perspective.

What was not “right” or feasible 20 years ago, today is a need. We must revisit the medical contraindications for organ acceptance in specific fields like infectious and neoplastic disease.

Because our aim is the best interest of the patients, we must guarantee that the transplant of this non-standard and non extended criteria donor is safe.

Workstream led by Giuseppe Feltrin and Nuria Masnou, moderated by Omar Taco

WS06 – HLA desensitization

This workstream focuses on discussing the  potential recipients with otherwise suitable donors who are relegated to the ever-expanding deceased-donor waiting list because of preformed human leukocyte antigen (HLA) antibodies (HLA sensitization) which may be acquired via pregnancy, transfusion, and/or prior transplant.

Workstream led by Nizam Mamode and moderated by Edoardo Melilli

This workstream is kindly supported by an unrestricted grant from HANSA

WS07 – COVID-19

Collaboration between members/countries of the ESOT community to analyse data retrospectively and to create a (flexible and regularly updated) guideline document to support the individuals (patients and clinicians) within the Transplant community in times of a pandemic.

Led and moderated by Vassilios Papalois


A full stream of mutual understanding and learning dedicated to Transplant
Donor Coordinators, Allied Healthcare Professionals, Ethical, Legal and
Psychosocial Aspects of Organ Transplantation and the European
Transplant Patient Organization (ETPO)

Led by Anna Forsberg, Nichon Jansen, Hannah Maple, Emma Massey, David Paredes

Coming soon